Effect on Blood Loss and Cost-Effectiveness of Pain Cocktails, Platelet-Rich Plasma, or Fibrin Sealant After Total Knee Arthroplasty

Journal of Arthroplasty

Volumn 27, Issue 8, 2012, Pages 1448-1451

  Bernasek, Thomas L ^a   Burris, R Brandon ^b   Fujii, Hideki ^c   Levering, Melissa F ^c   Polikandriotis, John A ^c   Patterson, Jared J ^a  

^a FLORIDA ORTHOPAEDIC INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c FOUNDATION FOR ORTHOPAEDIC RESEARCH AND EDUCATION   (United States)

Author keywords

Fibrin sealant; Pain cocktail; Platelet rich plasma; Total knee arthroplasty

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CEFUROXIME; FIBRIN GLUE; HEMOGLOBIN; METHYLPREDNISOLONE ACETATE; MORPHINE; ROPIVACAINE; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL COST; HUMAN; KNEE PROSTHESIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; POSTOPERATIVE THROMBOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THROMBOCYTE RICH PLASMA; TOTAL KNEE REPLACEMENT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; COST-BENEFIT ANALYSIS; FEMALE; FIBRIN TISSUE ADHESIVE; HUMANS; MALE; MIDDLE AGED; PLATELET-RICH PLASMA; RETROSPECTIVE STUDIES;

EID: 84865346904     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2012.02.018     Document Type: Article

References (14)

1. Lombardi A.V., Berend K.R., Mallory T.H., et al. Soft tissue and intra-articular injection of bupivacaine, epinephrine, and morphine has a beneficial effect after total knee arthroplasty. Clin Orthop Relat Res 2004, 125.
2. Anderson L.A., Engel G.M., Bruckner J.D., et al. Reduced blood loss after total knee arthroplasty with local injection of bupivacaine and epinephrine. J Knee Surg 2009, 22:130.
3. Peerbooms J.C., de Wolf G.S., Colaris J.W., et al. No positive effect of autologous platelet gel after total knee arthroplasty. Acta Orthop 2009, 80:557.
4. Everts P.A., Devilee R.J., Brown Mahoney C., et al. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand 2006, 50:593.
5. Gardner M.J., Demetrakopoulos D., Klepchick P.R., et al. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 2007, 31:309.
6. Cronkite E.P., Lozuer E.L., Deaver J. Use of thrombin and fibrinogen in skin grafting. JAMA 1944, 124:976.
7. Molloy D.O., Archbold H.A., Ogonda L., et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br 2007, 89:306.
8. Wang G.J., Hungerford D.S., Savory C.G., et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001, 83-A:1503.
9. Levy O., Martinowitz U., Oran A., et al. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 1999, 81:1580.
10. Bong M.R., Patel V., Chang E., et al. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004, 19:281.
11. Iorio R., Robb W.J., Healy W.L., et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am 2008, 90:1598.
12. Keating E.M., Meding J.B., Faris P.M., et al. Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 1998, 50.
13. Wong J., Abrishami A., El Beheiry H., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomised, controlled trial. J Bone Joint Surg Am 2010, 92:2503.
14. Steuten L., Vallejo-Torres L., Bastide P., et al. Analysing uncertainty around costs of innovative medical technologies: the case of fibrin sealant (QUIXIL) for total knee replacement. Health Policy 2009, 89:46.